Gene therapy shows promise against age-related macular degeneration

A study shows promise in slowing age-related macular degeneration (AMD). Researchers demonstrate for the first time that a gene therapy approach to deliver CD59, an inhibitor of complement, can significantly reduce uncontrolled blood vessel growth and cell death that is typical in AMD, the most common cause of blindness in the elderly.

Read the whole article on Science Daily

More from Science Daily